Dr. Bloom is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
210 White Building
Philadelphia, PA 19104Phone+1 215-662-2638Fax+1 215-349-5703- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Nephrology, 1992 - 1994
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1990 - 1992
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1987 - 1990
- University of the WitwatersrandClass of 1983
Certifications & Licensure
- PA State Medical License 1989 - 2024
- NJ State Medical License 2013 - 2019
- TX State Medical License 2018 - 2019
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients Start of enrollment: 2007 Mar 01
- Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation Start of enrollment: 2013 Aug 01
- Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants Start of enrollment: 2019 Nov 11
Publications & Presentations
PubMed
- 8 citationsShould Transplant Nephrology Pursue Recognition from the Accreditation Council for Graduate Medical Education (ACGME)?Neeraj Singh, Prince M Anand, Gaurav Gupta, Deirdre Sawinski, Oren Fix, Deborah Adey, Enver Akalin, Carlos Zayas, Darshana Dadhania, Mona Doshi, Diane Cibrik, Mallika ...> ;Clinical Journal of the American Society of Nephrology. 2024 Feb 6
- Outcomes in kidney transplant recipients treated with immediate-release tacrolimus capsules versus extended-release tacrolimus capsules: A cohort study.Yoonhee P Ha, Gillian Divard, Nandita Mitra, Mary E Putt, Nicolas Pallet, Alexandre Loupy, Dany Anglicheau, Jennifer Trofe-Clark, Christophe Legendre, Roy D Bloom, Pet...> ;Clinical Transplantation. 2023 Jan 1
- 1 citationsSocial and Financial Implications of Medicare Part B Immunosuppressive Drug Benefits for Kidney Transplant Recipients: A View From the Trenches.Jordan C Shaffer, Roy D Bloom> ;American Journal of Kidney Diseases. 2023 Jan 1
- Join now to see all
Journal Articles
- Twelve-Month Outcomes After Transplant of Hepatitis C–infected Kidneys into Uninfected Recipients: A Single-Group TrialDavid S Goldberg, Roy D Bloom, Vishnu S Potluri, Susanna M Nazarian, Ali Naji, Emily A Blumberg, Peter L Abt, Peter P Reese, Matthew Levine, Paige Porrett, Melissa Ble..., Annals of Internal Medicine
Lectures
- Using (Cell‐Free) DNA to Incriminate Rejection as the Cause of Kidney Allograft Dysfunction: Do We Have a Verdict?American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
Other
- Using (Cell‐Free) DNA to Incriminate Rejection as the Cause of Kidney Allograft Dysfunction: Do We Have a Verdict?Roy Bloom, MD, American Journal of Transplantation
https://www.doximity.com/articles/eb68afef-d890-48c4-9b39-b139efe7ddab
UpToDate, Wolters Kluwer Health - 2012-02-09
Press Mentions
- CareDx to Present Key AlloSure Validation Data at ATCApril 28th, 2017
- AlloSure Featured in Journal of the American Society of NephrologyMarch 9th, 2017
- US Policy That Gives Priority to Prior Organ Donors Who Need a Transplant Is WorkingNovember 24th, 2014
- Join now to see all
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: